Anti-DNJC9/ DNAJC9/ HDJC9 monoclonal antibody

Anti-DNJC9/ DNAJC9/ HDJC9 antibody for FACS & in-vivo assay

Target products collectionGo to DNAJC9/DNAJC9 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2086-Ab-1/ GM-Tg-hg-MP2086-Ab-2Anti-Human DNAJC9 monoclonal antibodyHuman
GM-Tg-rg-MP2086-Ab-1/ GM-Tg-rg-MP2086-Ab-2Anti-Rat DNAJC9 monoclonal antibodyRat
GM-Tg-mg-MP2086-Ab-1/ GM-Tg-mg-MP2086-Ab-2Anti-Mouse DNAJC9 monoclonal antibodyMouse
GM-Tg-cynog-MP2086-Ab-1/ GM-Tg-cynog-MP2086-Ab-2Anti-Cynomolgus/ Rhesus macaque DNAJC9 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2086-Ab-1/ GM-Tg-felg-MP2086-Ab-2Anti-Feline DNAJC9 monoclonal antibodyFeline
GM-Tg-cang-MP2086-Ab-1/ GM-Tg-cang-MP2086-Ab-2Anti-Canine DNAJC9 monoclonal antibodyCanine
GM-Tg-bovg-MP2086-Ab-1/ GM-Tg-bovg-MP2086-Ab-2Anti-Bovine DNAJC9 monoclonal antibodyBovine
GM-Tg-equg-MP2086-Ab-1/ GM-Tg-equg-MP2086-Ab-2Anti-Equine DNAJC9 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2086-Ab-1/ GM-Tg-hg-MP2086-Ab-2; GM-Tg-rg-MP2086-Ab-1/ GM-Tg-rg-MP2086-Ab-2;
GM-Tg-mg-MP2086-Ab-1/ GM-Tg-mg-MP2086-Ab-2; GM-Tg-cynog-MP2086-Ab-1/ GM-Tg-cynog-MP2086-Ab-2;
GM-Tg-felg-MP2086-Ab-1/ GM-Tg-felg-MP2086-Ab-2; GM-Tg-cang-MP2086-Ab-1/ GM-Tg-cang-MP2086-Ab-2;
GM-Tg-bovg-MP2086-Ab-1/ GM-Tg-bovg-MP2086-Ab-2; GM-Tg-equg-MP2086-Ab-1/ GM-Tg-equg-MP2086-Ab-2
Products NameAnti-DNAJC9 monoclonal antibody
Formatmab
Target NameDNAJC9
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-DNAJC9 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species DNJC9/ DNAJC9/ HDJC9 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP2086
    Target NameDNAJC9
    Gene ID23234,108671,364240,707599,489047,101085154,510898,100072848
    Gene Symbol and Synonyms5330419I01Rik,DNAJC9,HDJC9,JDD1,SB73
    Uniprot AccessionQ8WXX5
    Uniprot Entry NameDNJC9_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000213551
    Target ClassificationN/A

    The target: DNAJC9, gene name: DNAJC9, also named as HDJC9, JDD1, SB73. Enables chaperone binding activity; heat shock protein binding activity; and histone binding activity. Involved in nucleosome assembly and positive regulation of ATPase activity. Located in several cellular components, including cytosol; extracellular space; and nucleoplasm. Part of chaperone complex. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.